PI16
Peptidase inhibitor 16
Also known as: CD364, dJ90K10.5, MGC45378, MSMBBP, PI16_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6UXB8
- Gene
- PI16
- Ensembl
- ENSG00000164530
- Chromosome
- 6
- Canonical length
- 463 aa
- Protein class
- CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
Predicted to enable peptidase inhibitor activity. Predicted to act upstream of or within negative regulation of cell growth involved in cardiac muscle cell development. Predicted to be located in extracellular region. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
463 residues, UniProt reviewed canonical sequence.
>Q6UXB8|PI16
1 MHGSCSFLML LLPLLLLLVA TTGPVGALTD EEKRLMVELH NLYRAQVSPT ASDMLHMRWD
61 EELAAFAKAY ARQCVWGHNK ERGRRGENLF AITDEGMDVP LAMEEWHHER EHYNLSAATC
121 SPGQMCGHYT QVVWAKTERI GCGSHFCEKL QGVEETNIEL LVCNYEPPGN VKGKRPYQEG
181 TPCSQCPSGY HCKNSLCEPI GSPEDAQDLP YLVTEAPSFR ATEASDSRKM GTPSSLATGI
241 PAFLVTEVSG SLATKALPAV ETQAPTSLAT KDPPSMATEA PPCVTTEVPS ILAAHSLPSL
301 DEEPVTFPKS THVPIPKSAD KVTDKTKVPS RSPENSLDPK MSLTGARELL PHAQEEAEAE
361 AELPPSSEVL ASVFPAQDKP GELQATLDHT GHTSSKSLPN FPNTSATANA TGGRALALQS
421 SLPGAEGPDK PSVVSGLNSG PGHVWGPLLG LLLLPPLVLA GIFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PI16 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 143 nTPM
Expression across tissuesHPA
Tissue
- vagina: 143 nTPM
- heart muscle: 141 nTPM
- cervix: 132 nTPM
- urinary bladder: 108 nTPM
- breast: 62 nTPM
- skin: 56 nTPM
Single-cell type
- leydig cells: 336 nCPM
- fibroblasts: 226 nCPM
- peritubular myoid cells: 199 nCPM
- hepatic stellate cells: 161 nCPM
- fibro-adipogenic progenitors: 130 nCPM
- oligodendrocytes: 52 nCPM
Immune cell
- T-reg: 66 nTPM
- memory CD4 T-cell: 20 nTPM
- NK-cell: 14 nTPM
- naive CD4 T-cell: 6.5 nTPM
- memory CD8 T-cell: 5.7 nTPM
- total PBMC: 3.3 nTPM
Brain region
- white matter: 27 nTPM
- basal ganglia: 23 nTPM
- thalamus: 21 nTPM
- hypothalamus: 21 nTPM
- medulla oblongata: 20 nTPM
- pons: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.31
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.05
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PI16 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PI16 as an antibody target. Whether an autoantibody or antibody against PI16 could matter depends on whether native PI16 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PI16 is annotated as secreted, so native PI16 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label PI16 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...